Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Activation of the
EPO-R
[EPO (erythropoietin) receptor] by its ligand EPO promotes erythropoiesis. Low cell surface
EPO-R
levels are traditionally attributed to inefficient folding mediated by the receptor extracellular domain. In the present study, we addressed the role of the
EPO-R
intracellular domain in exit from the ER (endoplasmic reticulum) and surface expression. A fusion protein between the thermo-reversible folding mutant of VSVG (vesicular-
stomatitis
-virus glycoprotein) (VSVGtsO45) and the
EPO-R
cytosolic domain [VSVG-WT (wild-type)] displayed delayed intracellular trafficking as compared with the parental VSVGtsO45, suggesting that the
EPO-R
cytosolic domain can hamper ER exit. Although NPXY-based motifs were originally associated with clathrin binding and endocytosis, they may also function in other contexts of the secretory pathway. A fusion protein between VSVGtsO45 and the cytosolic portion of
EPO-R
containing an NPVY insert (VSVG-NPVY) displayed enhanced glycan maturation and surface expression as compared with VSVG-WT. Notably, the NPVY insert also conferred improved maturation and augmented cell surface
EPO-R
. Our findings highlight three major concepts: (i) the
EPO-R
cytosolic domain is involved in ER exit of the receptor. (ii) Sequence motifs that participate in endocytosis can also modulate transport along the secretory pathway. (iii) VSVG-fusion proteins may be employed to screen for intracellular sequences that regulate transport.
...
PMID:A transplanted NPVY sequence in the cytosolic domain of the erythropoietin receptor enhances maturation. 1799 55
Lysine residues are key residues in many cellular processes, in part due to their ability to accept a wide variety of post-translational modifications. In the present study, we identify the
EPO-R
[EPO (erythropoietin) receptor] cytosolic lysine residues as enhancers of receptor function.
EPO-R
drives survival, proliferation and differentiation of erythroid progenitor cells via binding of its ligand EPO. We mutated the five
EPO-R
cytosolic lysine residues to arginine residues (5KR
EPO-R
), eliminating putative lysine-dependent modifications. Overexpressed 5KR
EPO-R
displayed impaired ubiquitination and improved stability compared with wt (wild-type)
EPO-R
. Unexpectedly, fusion proteins consisting of VSVGtsO45 (vesicular
stomatitis
virus glycoprotein temperature-sensitive folding mutant) with wt or 5KR
EPO-R
cytosolic domains demonstrated delayed glycan maturation kinetics upon substitution of the lysine residues. Moreover, VSVG-wt
EPO-R
, but not VSVG-5KR
EPO-R
, displayed endoplasmic reticulum-associated ubiquitination. Despite similar cell-surface EPO-binding levels of both receptors and the lack of EPO-induced ubiquitination by 5KR
EPO-R
, the lysine-less mutant produced weaker receptor activation and signalling than the wt receptor. We thus propose that
EPO-R
cytosolic lysine residues enhance receptor function, most probably through ubiquitination and/or other post-translational modifications.
...
PMID:Cytosolic lysine residues enhance anterograde transport and activation of the erythropoietin receptor. 2129 19